Switch to:
Alexion Pharmaceuticals Inc (NAS:ALXN)
Accounts Payable
$405 Mil (As of Sep. 2015)

Alexion Pharmaceuticals Inc's quarterly accounts payable increased from Mar. 2015 ($361 Mil) to Jun. 2015 ($454 Mil) but then declined from Jun. 2015 ($454 Mil) to Sep. 2015 ($405 Mil).

Alexion Pharmaceuticals Inc's annual accounts payable increased from Dec. 2012 ($228 Mil) to Dec. 2013 ($424 Mil) and increased from Dec. 2013 ($424 Mil) to Dec. 2014 ($439 Mil).


Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Alexion Pharmaceuticals Inc Annual Data

Accts Payable 2427378078123178228424439

Alexion Pharmaceuticals Inc Quarterly Data

Accts Payable 214280424232241301439361454405
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership